mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.8 |